VivoArchitect’s Post

Though improving diversity in #clinicaltrials is critical, it's not a simple endeavor, particularly for the small-to-mid-sized #biotech and #DTx companies. Early protocol design planning is crucial to ensure sponsors are meeting the current regulatory requirements. This may sound intimidating, however, Curavit makes it simple with our Inclusivity, #Diversity, and Equity in Action (#IDEA) Toolkit! Check out our toolkit, laid out step-by-step, with insightful expositions from Curavit's Solutions Manager, Natália Husby, in this Applied Clinical Trials Magazine article. https://lnkd.in/gg8HFRjA

TechBio is impacting the drug discovery process in different ways. Our corporate development manager Cam Watson was on the panel at ON Helix 2024. The discussion was generally focused around how there are more ways for drug discovery to use data in their approaches. This is allowing drug discovery to proceed more efficiently and identify new and exciting opportunities – including discovering how drugs can work in completely new ways or finding new targets altogether. Cam highlighted the importance in TechBio of bringing these insights into the real world and that technologies like our eProtein discovery™ were absolutely critical in this. “The really exciting aspect about TechBio”, Cam highlighted, “is that it’s making engineering biology more accessible and decentralized, meaning more people can engage with it and develop their own hypothesis.” Want to learn how we're changing the drug development game? Click the link ➡ http://eprote.in/fYj1zdI3 #ONHelix24 #proteinacess #drugdiscovery

This is evidence of how proper planning of #clinicaltrials can have a real impact on their speed and budget. Indegene achieved these incredible results for their client being backed by TrialHub's real-time insights on trials, sites, and patients. Very proud of this project 😊 You can read the full story on our blog (link in the comments) #patientrecruitment #dataanalytics #clinicaloperations #clinicalresearch #biotech #siteselection #patientfeasibility

A short success story in numbers result of the newest Technology for country, #sites, and #patients feasibility backing phase 3 #ClinicalTrial 👏 Indegene achieved these incredible results for their client being backed by TrialHub's real-time insights on trials, sites, and patients 🚀 The full story on our blog (link in the comments). #patientrecruitment #dataanalytics #clinicaloperations #clinicalresearch #biotech #siteselection #patientfeasibility

Think Bioscience is a great demonstration example of how the L7|ESP Platform, with its #WorkflowOrchestration system and #DataContexualization, can help modernize, adapt, and improve internal excel spreadsheet-based processes to formalize company-wide SOPs and to manage all entities and data in one #singlesourceoftruth. #digitalization #drugdiscovery #standardoperatingprocedures #labautomation #LIMS #laboratoryprocesses #L7LIMS #processautomation

🌟 Judith Eschbach and Pierre Eftekhari, two of the driving forces behind our latest scientific paper, are here to share insights in a special interview! 🚀🔬 📝 Title: "Drug Upgrade: a complete methodology from old drug to new chemical entities using Nematic Protein Organization Technique." 🔗 Read the full paper here: https://lnkd.in/gFSPBxsu In this interview, Judith and Pierre take us behind the scenes of our groundbreaking research, from inception to publication. Learn about the innovative approaches, collaborative efforts, and the transformative impact on drug development programs. 🧠 Gain a unique perspective on the challenges overcome and the opportunities uncovered. Judith and Pierre shed light on how this research shaped Inoviem Scientific commitment to optimize time and resources in the entire drug discovery process of our clients with a true patient-centric approach and proprietary technologies 👇 Feel free to share your thoughts and questions in the comments. Let's continue pushing the boundaries of knowledge! #Inoviem #drugdevelopment #drugdiscovery #clinicalphases #patientcentric #technology #innovations #healthcarefuture #personalizedmedicine 

Last day in ELRIGuk Research & Innovation 2024. Last moment to see and discuss with us in order to understand the beauty of BIOMIMESYS technology for better drug screening on 3D relevant human cellular models. #biomimesys = #breakthrough, #healthtech, #greentech, #animalfree

About our last publication on drug repositioning!

The article "What to watch in the life sciences in 2024" by Clarivate provides insights into upcoming trends and developments in the life sciences industry. It offers a preview of key areas to monitor for advancements and innovations in the field. Subjects discussed include emerging technologies that are poised to revolutionize drug development processes, anticipated market trends and shifts in the life sciences sector, regulatory updates and potential changes that could impact drug development and approval processes, and growing importance of patient-centric innovation in the life sciences. KSB is dedicated to advancing impactful therapies that address critical healthcare challenges by staying abreast of industry developments and embracing innovative approaches. Article link: https://lnkd.in/gcXNnTQU #LifeSciencesTrends #DrugDevelopment #MedicalInnovations #Biotech

We're pledging to support the iPSC community- so get in touch and let us know what we can do to help! As leaders in the iPSC market, we’re committed to supporting drug discovery scientists who seek to build better human disease models, fueled with iPSC-derived cells. Over the last year, we’ve continued our decade-long journey of investment into manufacturing scale and quality, and now we want to share those benefits with you. So in 2024, we’re pledging to drive further adoption, making it easier and more affordable to access and use market-leading iPSC technology. We’re going to be supporting those new to iPSCs, researchers already engaged with iPSC technology, and groups looking to scale up in size and complexity. So whether you're looking to use iPSCs for the first time or want to expand and scale up your projects, we can help. Take a look at our 2024 promotions and pricing structures to see how we can support you in your iPSC journey: https://hubs.la/Q02g6p7h0 Want to discuss a project? Get in touch with us at operations@axolbio.com #iPSCs #StemCells #DrugDiscovery #biotech